Plant Genomics in World Economy

The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Genomics play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests. This, coupled with growing prevalence of infectious diseases and hospital acquired infections is expected to drive market growth during the forecast period. Other driving factors for this market include decreasing prices of DNA sequencing, increasing demand for genome analysis in animal and plant feedstock, extensive presence of both private and public external funding programs and growing patient awareness levels. In addition, presence of untapped growth opportunities in emerging countries such as India, Brazil and China and the increasing health awareness are expected to serve this market as future growth opportunities.

Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomics based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population based therapeutic solutions and subsequent increase in R&D initiatives.

Market Size - $11.1 Billion in 2013, Market Growth - CAGR of 10.3% from 2014 to 2020, Market Trends - Growing demand for personalized medicine and the consequent rise in demand for genomics based R&D initiatives is expected to drive market growth during the forecast period

 

- See more at: http://plantgenomics.conferenceseries.com/#section2

The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Genomics play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests. This, coupled with growing prevalence of infectious diseases and hospital acquired infections is expected to drive market growth during the forecast period. Other driving factors for this market include decreasing prices of DNA sequencing, increasing demand for genome analysis in animal and plant feedstock, extensive presence of both private and public external funding programs and growing patient awareness levels. In addition, presence of untapped growth opportunities in emerging countries such as India, Brazil and China and the increasing health awareness are expected to serve this market as future growth opportunities.

Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomics based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population based therapeutic solutions and subsequent increase in R&D initiatives.

Market Size - $11.1 Billion in 2013, Market Growth - CAGR of 10.3% from 2014 to 2020, Market Trends - Growing demand for personalized medicine and the consequent rise in demand for genomics based R&D initiatives is expected to drive market growth during the forecast period

 

- See more at: http://plantgenomics.conferenceseries.com/#section2

The global market for genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Genomics play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests. This, coupled with growing prevalence of infectious diseases and hospital acquired infections is expected to drive market growth during the forecast period. Other driving factors for this market include decreasing prices of DNA sequencing, increasing demand for genome analysis in animal and plant feedstock, extensive presence of both private and public external funding programs and growing patient awareness levels. In addition, presence of untapped growth opportunities in emerging countries such as India, Brazil and China and the increasing health awareness are expected to serve this market as future growth opportunities.

 

Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs. Genomics based personalized medicine segment on the other hand is expected to grow at the fastest CAGR of over 12.0% from 2014 to 2020 due to increasing demand for population based therapeutic solutions and subsequent increase in R&D initiatives.

Plant Genomics Market Size - $11.1 Billion in 2013, Market Growth - CAGR of 10.3% from 2014 to 2020, Market Trends - Growing demand for personalized medicine and the consequent rise in demand for genomics based R&D initiatives is expected to drive market growth during the forecast period

  • Plant genomics products and analysis
  • Plant genomics innovations in USA
  • Plant genomics research in USA
  • Plant genomics scope in UK
  • Plant Genomics trials in USA and Europe
  • Plant genomics in Asia

Related Conference of Plant Genomics in World Economy

Plant Genomics in World Economy Conference Speakers